Thomas J. Schuetz - 08 Feb 2023 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Thomas J. Schuetz
Issuer symbol
CMPX
Transactions as of
08 Feb 2023
Net transactions value
$0
Form type
4
Filing time
09 Feb 2023, 15:23:48 UTC
Previous filing
31 Jan 2023
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPX Common Stock Award $0 +500,000 +9.1% $0.000000 5,971,873 08 Feb 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +700,000 $0.000000 700,000 08 Feb 2023 CommonStock 700,000 $3.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSU") granted to the reporting person on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vesting on February 8, 2024.
F2 100,751 of these shares of common stock underlie unvested restricted stock awards that are subject to a right of repurchase in favor of the issuer, which vest as follows: restricted stock award granted on July 3, 2019, with the remaining 33,525 shares vesting approximately equally per month with shares fully vested on July 31, 2023 and restricted stock award granted on December 20, 2019, with the remaining 67,226 shares vesting approximately equally per month with shares fully vested on December 31, 2023. 450,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on November 16, 2021. 500,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 15, 2022.
F3 The options vest over 48 substantially equal monthly installments starting March 8, 2023.